{"id":3630,"date":"2020-03-24T10:48:00","date_gmt":"2020-03-24T09:48:00","guid":{"rendered":"https:\/\/dev.retina.ch\/?post_type=aktuelles&#038;p=3630"},"modified":"2020-11-20T09:49:12","modified_gmt":"2020-11-20T08:49:12","slug":"prise-de-position-du-svrg-concernant-le-traitement-anti-vegf-durant-la-pandemie-covid-19","status":"publish","type":"aktuelles","link":"https:\/\/retina.ch\/fr\/actualites\/prise-de-position-du-svrg-concernant-le-traitement-anti-vegf-durant-la-pandemie-covid-19\/","title":{"rendered":"Prise de position du SVRG concernant le traitement anti-VEGF durant la pand\u00e9mie COVID-19"},"content":{"rendered":"\n<p>Le 16 mars 2020, le Conseil f\u00e9d\u00e9ral suisse a d\u00e9cr\u00e9t\u00e9 l\u2019ordonnance sur les mesures destin\u00e9es \u00e0 lutter contre le coronavirus COVID-19. L\u2019article 10a stipule que les \u00e9tablissements de sant\u00e9 doivent renoncer \u00e0 tous les traitements et interventions m\u00e9dicaux non urgents.<\/p>\n\n\n\n<p>De l\u2019avis du Comit\u00e9 directeur du SVRG, la plupart des th\u00e9rapies avec des anti-VEGF, notamment en cas de d\u00e9g\u00e9n\u00e9rescence maculaire li\u00e9e \u00e0 l\u2019\u00e2ge, constituent des traitements urgents, \u00e9tant donn\u00e9 que tout retard dans la mise en \u0153uvre du traitement ou l\u2019absence de traitement risque d\u2019induire une perte de vision permanente. Le traitement doit donc \u00eatre poursuivi.<\/p>\n\n\n\n<p>Afin de minimiser le risque d\u2019infection par le COVID-19 chez les patients faisant partie de ce groupe \u00e0 risque, le Comit\u00e9 directeur du SVRG pr\u00e9conise les mesures suivantes:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Aucune mesure diagnostique (OCT, examen du fond de l\u2019\u0153il, d\u00e9termination de la vision etc.) dans le cas de th\u00e9rapies d\u00e9j\u00e0 \u00e9tablies et d\u2019une \u00e9volution subjectivement favorable<\/li><li>Poursuite des injections en se fixant sur le dernier intervalle de traitement chez les patients soumis \u00e0 un protocole Treat and Extend<\/li><li>Poursuite des injections chez les patients en pro re nata selon l\u2019intervalle le plus court des 6 derniers mois<\/li><li>En cas de nouvelle suspicion de CNV, proc\u00e9der au diagnostic courant. Angiographie par fluorescence uniquement si le diagnostic n\u2019est pas clair \u00e0 l\u2019OCT.<\/li><li>Afin de minimiser la dur\u00e9e des contacts dans l\u2019\u00e9tablissement de sant\u00e9, les rendez-vous ne doivent plus \u00eatre donn\u00e9s sur place, mais par t\u00e9l\u00e9phone.<\/li><li>Il convient de veiller strictement au respect des recommandations du Conseil f\u00e9d\u00e9ral en mati\u00e8re de \u00abdistanciation sociale\u00bb. Les temps d\u2019attente doivent notamment \u00eatre r\u00e9duits, et les salles d\u2019attente doivent \u00eatre am\u00e9nag\u00e9es de telle sorte que les distances ne puissent pas \u00eatre inf\u00e9rieures \u00e0 celles recommand\u00e9es. Les accompagnants doivent attendre en-dehors de l\u2019\u00e9tablissement de sant\u00e9.<\/li><li>Utilisation des possibilit\u00e9s de t\u00e9l\u00e9m\u00e9decine telles les consultations par t\u00e9l\u00e9phone pour l\u2019anamn\u00e8se interm\u00e9diaire. Il est particuli\u00e8rement important durant cette p\u00e9riode d\u2019auto-isolement forc\u00e9 de ne pas laisser les patients seuls avec leur maladie et les angoisses qui y sont li\u00e9es.<\/li><li>Utilisation de mesures d\u2019auto-surveillance, telles que grille d\u2019Amsler, test Alleye, etc.<\/li><\/ul>\n\n\n\n<p>Le Comit\u00e9 directeur du SVRG pense que les mesures pr\u00e9conis\u00e9es ci-dessus contribueront, chez ce groupe de patients vuln\u00e9rables, \u00e0 pr\u00e9server le tr\u00e8s bon rapport b\u00e9n\u00e9fice-risque du traitement anti-VEGF, et ce, m\u00eame pendant la pand\u00e9mie COVID-19.<\/p>\n\n\n\n<p>Le Comit\u00e9 directeur du Swiss Vitreoretinal Group<\/p>\n\n\n\n<p>Mise \u00e0 jour le 17 mars 2020<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Recommandations du conseil d&rsquo;administration du SVRG pour minimiser le risque d&rsquo;infection par COVID-19 chez les patients.<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"_FSMCFIC_featured_image_caption":"","_FSMCFIC_featured_image_nocaption":"","_FSMCFIC_featured_image_hide":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[],"class_list":["post-3630","aktuelles","type-aktuelles","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Prise de position du SVRG concernant le traitement anti-VEGF durant la pand\u00e9mie COVID-19 &#8226; Retina Suisse<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/retina.ch\/fr\/actualites\/prise-de-position-du-svrg-concernant-le-traitement-anti-vegf-durant-la-pandemie-covid-19\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prise de position du SVRG concernant le traitement anti-VEGF durant la pand\u00e9mie COVID-19 &#8226; Retina Suisse\" \/>\n<meta property=\"og:description\" content=\"Recommandations du conseil d&#039;administration du SVRG pour minimiser le risque d&#039;infection par COVID-19 chez les patients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/retina.ch\/fr\/actualites\/prise-de-position-du-svrg-concernant-le-traitement-anti-vegf-durant-la-pandemie-covid-19\/\" \/>\n<meta property=\"og:site_name\" content=\"Retina Suisse\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/retinasuisse\/\" \/>\n<meta property=\"article:modified_time\" content=\"2020-11-20T08:49:12+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/retina.ch\/fr\/actualites\/prise-de-position-du-svrg-concernant-le-traitement-anti-vegf-durant-la-pandemie-covid-19\/\",\"url\":\"https:\/\/retina.ch\/fr\/actualites\/prise-de-position-du-svrg-concernant-le-traitement-anti-vegf-durant-la-pandemie-covid-19\/\",\"name\":\"Prise de position du SVRG concernant le traitement anti-VEGF durant la pand\u00e9mie COVID-19 &#8226; Retina Suisse\",\"isPartOf\":{\"@id\":\"https:\/\/retina.ch\/fr\/#website\"},\"datePublished\":\"2020-03-24T09:48:00+00:00\",\"dateModified\":\"2020-11-20T08:49:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/retina.ch\/fr\/actualites\/prise-de-position-du-svrg-concernant-le-traitement-anti-vegf-durant-la-pandemie-covid-19\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/retina.ch\/fr\/actualites\/prise-de-position-du-svrg-concernant-le-traitement-anti-vegf-durant-la-pandemie-covid-19\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/retina.ch\/fr\/actualites\/prise-de-position-du-svrg-concernant-le-traitement-anti-vegf-durant-la-pandemie-covid-19\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Retina Suisse\",\"item\":\"https:\/\/retina.ch\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/retina.ch\/fr\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Prise de position du SVRG concernant le traitement anti-VEGF durant la pand\u00e9mie COVID-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/retina.ch\/fr\/#website\",\"url\":\"https:\/\/retina.ch\/fr\/\",\"name\":\"Retina Suisse\",\"description\":\"Retina Suisse ist die Vereinigung von Patientinnen und Patienten mit Retinitis pigmentosa (RP), Makuladegeneration, Usher-Syndrom und anderen Erkrankungen des Augenhintergrundes.\",\"publisher\":{\"@id\":\"https:\/\/retina.ch\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/retina.ch\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/retina.ch\/fr\/#organization\",\"name\":\"Retina Suisse\",\"url\":\"https:\/\/retina.ch\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/retina.ch\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/retina.ch\/wp-content\/uploads\/2020\/09\/retina-auge-typo.svg\",\"contentUrl\":\"https:\/\/retina.ch\/wp-content\/uploads\/2020\/09\/retina-auge-typo.svg\",\"width\":\"1024\",\"height\":\"1024\",\"caption\":\"Retina Suisse\"},\"image\":{\"@id\":\"https:\/\/retina.ch\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/retinasuisse\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Prise de position du SVRG concernant le traitement anti-VEGF durant la pand\u00e9mie COVID-19 &#8226; Retina Suisse","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/retina.ch\/fr\/actualites\/prise-de-position-du-svrg-concernant-le-traitement-anti-vegf-durant-la-pandemie-covid-19\/","og_locale":"fr_FR","og_type":"article","og_title":"Prise de position du SVRG concernant le traitement anti-VEGF durant la pand\u00e9mie COVID-19 &#8226; Retina Suisse","og_description":"Recommandations du conseil d'administration du SVRG pour minimiser le risque d'infection par COVID-19 chez les patients.","og_url":"https:\/\/retina.ch\/fr\/actualites\/prise-de-position-du-svrg-concernant-le-traitement-anti-vegf-durant-la-pandemie-covid-19\/","og_site_name":"Retina Suisse","article_publisher":"https:\/\/www.facebook.com\/retinasuisse\/","article_modified_time":"2020-11-20T08:49:12+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/retina.ch\/fr\/actualites\/prise-de-position-du-svrg-concernant-le-traitement-anti-vegf-durant-la-pandemie-covid-19\/","url":"https:\/\/retina.ch\/fr\/actualites\/prise-de-position-du-svrg-concernant-le-traitement-anti-vegf-durant-la-pandemie-covid-19\/","name":"Prise de position du SVRG concernant le traitement anti-VEGF durant la pand\u00e9mie COVID-19 &#8226; Retina Suisse","isPartOf":{"@id":"https:\/\/retina.ch\/fr\/#website"},"datePublished":"2020-03-24T09:48:00+00:00","dateModified":"2020-11-20T08:49:12+00:00","breadcrumb":{"@id":"https:\/\/retina.ch\/fr\/actualites\/prise-de-position-du-svrg-concernant-le-traitement-anti-vegf-durant-la-pandemie-covid-19\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/retina.ch\/fr\/actualites\/prise-de-position-du-svrg-concernant-le-traitement-anti-vegf-durant-la-pandemie-covid-19\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/retina.ch\/fr\/actualites\/prise-de-position-du-svrg-concernant-le-traitement-anti-vegf-durant-la-pandemie-covid-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Retina Suisse","item":"https:\/\/retina.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Actualit\u00e9s","item":"https:\/\/retina.ch\/fr\/actualites\/"},{"@type":"ListItem","position":3,"name":"Prise de position du SVRG concernant le traitement anti-VEGF durant la pand\u00e9mie COVID-19"}]},{"@type":"WebSite","@id":"https:\/\/retina.ch\/fr\/#website","url":"https:\/\/retina.ch\/fr\/","name":"Retina Suisse","description":"Retina Suisse ist die Vereinigung von Patientinnen und Patienten mit Retinitis pigmentosa (RP), Makuladegeneration, Usher-Syndrom und anderen Erkrankungen des Augenhintergrundes.","publisher":{"@id":"https:\/\/retina.ch\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/retina.ch\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/retina.ch\/fr\/#organization","name":"Retina Suisse","url":"https:\/\/retina.ch\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/retina.ch\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/retina.ch\/wp-content\/uploads\/2020\/09\/retina-auge-typo.svg","contentUrl":"https:\/\/retina.ch\/wp-content\/uploads\/2020\/09\/retina-auge-typo.svg","width":"1024","height":"1024","caption":"Retina Suisse"},"image":{"@id":"https:\/\/retina.ch\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/retinasuisse\/"]}]}},"_links":{"self":[{"href":"https:\/\/retina.ch\/fr\/wp-json\/wp\/v2\/aktuelles\/3630","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/retina.ch\/fr\/wp-json\/wp\/v2\/aktuelles"}],"about":[{"href":"https:\/\/retina.ch\/fr\/wp-json\/wp\/v2\/types\/aktuelles"}],"version-history":[{"count":0,"href":"https:\/\/retina.ch\/fr\/wp-json\/wp\/v2\/aktuelles\/3630\/revisions"}],"wp:attachment":[{"href":"https:\/\/retina.ch\/fr\/wp-json\/wp\/v2\/media?parent=3630"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/retina.ch\/fr\/wp-json\/wp\/v2\/categories?post=3630"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}